{
 "drug": "Allopurinol Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "02/19/2026",
 "dayN": 187,
 "cat": "Oncology",
 "companies": [
  "Teva Pharmaceuticals USA, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "02/19/2026",
   "update_type": "New",
   "initial_posting_date": "02/19/2026",
   "package_ndc": "0591-5544-01",
   "generic_name": "Allopurinol Tablet",
   "contact_info": "800-545-8800",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA018877"
    ],
    "brand_name": [
     "ALLOPURINOL"
    ],
    "generic_name": [
     "ALLOPURINOL"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-5544",
     "0591-5543"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ALLOPURINOL"
    ],
    "rxcui": [
     "197319",
     "197320"
    ],
    "spl_id": [
     "f7e04d88-1d9b-47e6-a9ad-deb08af3c098"
    ],
    "spl_set_id": [
     "a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"
    ],
    "package_ndc": [
     "0591-5543-01",
     "0591-5543-10",
     "0591-5544-01",
     "0591-5544-05"
    ],
    "nui": [
     "N0000175698",
     "N0000000206"
    ],
    "pharm_class_epc": [
     "Xanthine Oxidase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Xanthine Oxidase Inhibitors [MoA]"
    ],
    "unii": [
     "63CZ7GJN5I"
    ]
   },
   "update_date": "02/19/2026",
   "therapeutic_category": [
    "Oncology",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/19/2026",
   "update_type": "New",
   "initial_posting_date": "02/19/2026",
   "package_ndc": "0591-5544-05",
   "generic_name": "Allopurinol Tablet",
   "contact_info": "800-545-8800",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA018877"
    ],
    "brand_name": [
     "ALLOPURINOL"
    ],
    "generic_name": [
     "ALLOPURINOL"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-5544",
     "0591-5543"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ALLOPURINOL"
    ],
    "rxcui": [
     "197319",
     "197320"
    ],
    "spl_id": [
     "f7e04d88-1d9b-47e6-a9ad-deb08af3c098"
    ],
    "spl_set_id": [
     "a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"
    ],
    "package_ndc": [
     "0591-5543-01",
     "0591-5543-10",
     "0591-5544-01",
     "0591-5544-05"
    ],
    "nui": [
     "N0000175698",
     "N0000000206"
    ],
    "pharm_class_epc": [
     "Xanthine Oxidase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Xanthine Oxidase Inhibitors [MoA]"
    ],
    "unii": [
     "63CZ7GJN5I"
    ]
   },
   "update_date": "02/19/2026",
   "therapeutic_category": [
    "Oncology",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/19/2026",
   "update_type": "New",
   "initial_posting_date": "02/19/2026",
   "package_ndc": "0591-5543-10",
   "generic_name": "Allopurinol Tablet",
   "contact_info": "800-545-8800",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA018832"
    ],
    "brand_name": [
     "ALLOPURINOL"
    ],
    "generic_name": [
     "ALLOPURINOL"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-5543",
     "0591-5544"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ALLOPURINOL"
    ],
    "rxcui": [
     "197319",
     "197320"
    ],
    "spl_id": [
     "f7e04d88-1d9b-47e6-a9ad-deb08af3c098"
    ],
    "spl_set_id": [
     "a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"
    ],
    "package_ndc": [
     "0591-5543-01",
     "0591-5543-10",
     "0591-5544-01",
     "0591-5544-05"
    ],
    "nui": [
     "N0000175698",
     "N0000000206"
    ],
    "pharm_class_epc": [
     "Xanthine Oxidase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Xanthine Oxidase Inhibitors [MoA]"
    ],
    "unii": [
     "63CZ7GJN5I"
    ]
   },
   "update_date": "02/19/2026",
   "therapeutic_category": [
    "Oncology",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "02/19/2026",
   "update_type": "New",
   "initial_posting_date": "02/19/2026",
   "package_ndc": "0591-5543-01",
   "generic_name": "Allopurinol Tablet",
   "contact_info": "800-545-8800",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA018832"
    ],
    "brand_name": [
     "ALLOPURINOL"
    ],
    "generic_name": [
     "ALLOPURINOL"
    ],
    "manufacturer_name": [
     "Actavis Pharma, Inc."
    ],
    "product_ndc": [
     "0591-5543",
     "0591-5544"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "ALLOPURINOL"
    ],
    "rxcui": [
     "197319",
     "197320"
    ],
    "spl_id": [
     "f7e04d88-1d9b-47e6-a9ad-deb08af3c098"
    ],
    "spl_set_id": [
     "a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"
    ],
    "package_ndc": [
     "0591-5543-01",
     "0591-5543-10",
     "0591-5544-01",
     "0591-5544-05"
    ],
    "nui": [
     "N0000175698",
     "N0000000206"
    ],
    "pharm_class_epc": [
     "Xanthine Oxidase Inhibitor [EPC]"
    ],
    "pharm_class_moa": [
     "Xanthine Oxidase Inhibitors [MoA]"
    ],
    "unii": [
     "63CZ7GJN5I"
    ]
   },
   "update_date": "02/19/2026",
   "therapeutic_category": [
    "Oncology",
    "Renal",
    "Rheumatology"
   ],
   "dosage_form": "Tablet",
   "presentation": "Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)",
   "company_name": "Teva Pharmaceuticals USA, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}